Insider Transactions in Q1 2023 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2023
|
Cintia Piccina Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,890
-37.84%
|
$11,890
$1.87 P/Share
|
|
Jan 17
2023
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,057
-42.96%
|
$10,057
$1.86 P/Share
|
|
Jan 17
2023
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,159
-38.21%
|
$2,159
$1.86 P/Share
|
|
Jan 17
2023
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,440
-37.94%
|
$4,440
$1.86 P/Share
|
|
Jan 17
2023
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
4,440
-37.94%
|
$4,440
$1.86 P/Share
|
|
Jan 12
2023
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,763
-42.99%
|
$18,763
$1.71 P/Share
|
|
Jan 12
2023
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,449
-37.93%
|
$7,449
$1.71 P/Share
|
|
Jan 12
2023
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
4,973
-37.98%
|
$4,973
$1.71 P/Share
|
|
Jan 12
2023
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,973
-37.98%
|
$4,973
$1.71 P/Share
|
|
Jan 11
2023
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,042
-42.99%
|
$13,042
$1.75 P/Share
|
|
Jan 11
2023
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,843
-38.0%
|
$3,843
$1.75 P/Share
|
|
Jan 11
2023
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
3,843
-38.0%
|
$3,843
$1.75 P/Share
|
|
Jan 11
2023
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,843
-38.0%
|
$3,843
$1.75 P/Share
|
|
Jan 04
2023
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,073
-43.34%
|
$5,073
$1.69 P/Share
|
|
Jan 04
2023
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
876
-39.16%
|
$876
$1.69 P/Share
|
|
Jan 04
2023
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
1,100
-38.94%
|
$1,100
$1.69 P/Share
|
|
Jan 04
2023
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,584
-38.27%
|
$3,584
$1.69 P/Share
|